rare disease
The Economic Ripple of Rare‑Disease Data Centers: How AI‑Powered Registries Cut Costs and Accelerate Care
The Economic Ripple of Rare-Disease Data Centers In 2026, GeneDx presented 18 abstracts at the ACMG meeting, highlighting its rare-disease data platform. This effort directly answers the question: Do centralized rare-disease databases generate measurable economic savings? The answer is yes - by consolidating genomic data, AI tools reduce diagnostic time